Anti-RSV Fusion Protein Antibody, clone 131-2A ZooMAb® Mouse Monoclonal,25UL,ZMS1055-25UL,Sigma

销售价: ¥ 2299.13 / 件
在线询价
优    惠: 请询价
订货号 0BR9977
品牌型号 Sigma ZMS1055-25UL
货期 询货期
最小订货量 1件
联系我们
  • 400-920-3909
微信扫一扫,手机采购
  • 商品介绍
  • 规格参数
  • 包装参数
产品介绍 Product Description

General description

Fusion glycoprotein F0 (UniProt: P03420) is encoded by the F gene (Gene ID: 1494475) in Human respiratory syncytial virus A (strain A2). Human respiratory syncytial virus (hRSV) is a pneumovirus that causes significant respiratory disease in premature and full-term infants. Fusion glycoprotein F0 of RSV is synthesized with a signal peptide (aa 1-15), which is subsequently cleaved off. The inactive F0 precursor is then cleaved at two sites (aa 109-110 and 136-137) by furin-like protease to give rise to produce mature F1 and F2 fusion glycoproteins. Fusion glycoprotein F1 is a single-pass type I membrane protein that can exist as homotrimer or can form disulfide-linked heterodimer with fusion glycoprotein F2. Its N-terminus has a hydrophobic fusion peptide that inserts into the target host membrane. It is buried in the center of the trimer cavity before cleavage by host furin. The fusion glycoprotein F2 is the major determinant of the species specificity of RSV infection. Fusion protein can exist in at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the coiled coil regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. This fusion is pH independent and occurs at the plasma or endosomal membrane. The fusion protein is reported to be involved in the entry into the host cell through the interaction with host IGF-R1. This interaction activates protein kinase z that recruits host NCL/nucleolin to the apical cell surface where it can bind fusion glycoprotein F1. Later in infection, fusion protein expressed at the plasma membrane of infected cells can mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis. Fusion protein can also trigger p53-dependent apoptosis in cells. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: McLellan, JS., et al. (2013). Science. 340(6136); 1113-1117; Olivier, A., et al. (2009). Int. J. Exp. Pathol. 90(4); 431-438; Schlender, J., et al. (2003). J. Virol. 77(8); 4609-4616).
We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.


Immunogen

A2 Respiratory Syncytial Virus (RSV) extract.


Application

Quality Control Testing

Evaluated by Immunocytochemistry in RSV infected HEp-2 cells.

Immunocytochemistry Analysis (ICC): A 1:1,000 dilution of this antibody detected RSV Fusion Protein in RSV infected HEp-2 cells.

Tested applications

Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected RSV Fusion Protein in lysate from RSV infected HEp-2 cells.

Immunohistochemistry (Paraffin) Analysis: A 1:1,000 dilution from a representative lot detected RSV Fusion Protein in RSV infected HEp-2 cells.

ELISA Analysis: A representative lot detected RSV Fusion Protein in ELISA applications (Newby, J., et. al. (2017). Nat Commun. 8(1):833).

Flow Cytometry Analysis: 1 μg from a representative lot detected RSV Fusion Protein in one million RSV infected HEp-2 cells.

Flow Cytometry Analysis: A representative lot detected RSV Fusion Protein in Flow Cytometry applications (Preugschas, H.F., et. al. (2019). Cell Microbiol. 21(1):e12955).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user


Biochem/physiol Actions

Clone 131-2A is a Mouse recombinant monoclonal antibody that detects fusion protein in Respiratory syncytial virus (RSV).


Physical form

Purified recombinant mouse monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.


Preparation Note

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
Reconstitute lyophilized antibody pellet with 25μL of ultrapure water or Phosphate Buffered Saline (PBS). Please refer to our reconstitution protocol and the specific application guidance on the suggested starting dilutions and sample type.


Legal Information

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany


Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.


技术参数 Specifications
biological sourcemouse
Quality Level200
recombinantexpressed in HEK 293 cells
conjugateunconjugated
antibody formpurified antibody
antibody product typeprimary antibodies
clone131-2A, recombinant monoclonal
product lineZooMAb® learn more
formlyophilized
mol wtcalculated mol wt 63.45 kDa,observed mol wt ~45 kDa
purified byusing protein G
species reactivityvirus
packagingantibody small pack of 25 μL
greener alternative product characteristicsWaste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.
enhanced validationrecombinant expression
Learn more about Antibody Enhanced Validation
sustainabilityGreener Alternative Product
technique(s)ELISA: suitable,flow cytometry: suitable,immunocytochemistry: suitable,immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable,western blot: suitable
isotypeIgG2aκ
epitope sequenceUnknown
Protein ID accession no.QEI22738.1
UniProt accession no.P03420
greener alternative categoryAligned,
shipped inambient
storage temp.2-8°C
target post-translational modificationunmodified
长度(mm)
宽度(mm)
高度(mm)
重量(kg)
猜你喜欢

在线
客服

在线客服服务时间:09:00-18:00

微信扫码咨询

客服
热线

400-920-3909
客服服务热线 周一至周五(09:00-18:00)

微信
咨询

微信小程序 7X24小时在线咨询